Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

More people self-funding routine operations as NHS waiting lists hit record levels

October 25, 2021 Sales and Marketing

New data from the Private Healthcare Information Network (PHIN) reveals that people are increasingly opting to self-fund private treatment. This …
News

Novartis Phase III study into canakinumab does not meet primary endpoint

October 25, 2021 Sales and Marketing

Novartis have announced that their CANOPY-1 Phase III study, which evaluated the efficacy of canakinumab, did not meet its primary …
News

AstraZeneca biliary cancer drug shows improved survival rate in patients

October 25, 2021 Sales and Marketing

AstraZeneca has announced that its Imfinzi drug­­­, for the treatment of biliary tract cancer, has improved overall survival in patients …
News

Survey reveals efficacy of Pfizer and AstraZeneca vaccines against positive COVID-19 tests

October 18, 2021 Sales and Marketing

Data from the Coronavirus Infection Survey (CIS), and pillars 1 and 2 of the NHS Test and Trace have measured …
News

MindMaze and The Royal Buckinghamshire Hospital create brain repair platform

October 18, 2021 Sales and Marketing

MindMaze Healthcare, major leader in the multi billion-dollar digital neurotherapeutics market, has announced the first UK partnership for its MindPod™ …
News

Major trial proposes how to reduce ICU infections caused by staphylococcus aureus

October 18, 2021 Sales and Marketing

A major US hospital-based clinical trial has highlighted the benefit of using nasal decolonisation to reduce ICU infections caused by …
News

Valneva COVID-19 vaccine shown to be more effective than AstraZeneca candidate

October 18, 2021 Sales and Marketing

French biotech company, Valneva, has announced positive results from the Phase III trial of its inactivated, adjuvanted COVID-19 vaccine candidate, …
News
limbix

SparkRx depression therapeutic shown to cut depression symptoms in adolescents

October 11, 2021 Sales and Marketing FDA, Limbix, SparkRx

A new digital therapeutic available for use without prescription under the FDA’s emergency guidance for digital health devices has shown …
News

NICE approves treatment for rheumatoid arthritis

October 11, 2021 Sales and Marketing

NICE has issued a positive final appraisal document recommending upadacitinib, a once-daily oral therapy, for people with previously treated moderate …
News
1109181692_a148e995c4_c

AlzeCure’s Alzheimer project initiates Phase I study

October 4, 2021 Sales and Marketing

Swedish pharmaceutical company AlzeCure Pharma AB has announced the initiation of the company’s next clinical Phase I trial (multiple ascending …
News

SEED invests in CBD brand business

October 4, 2021 Sales and Marketing

SEED Innovations Ltd has announced that it has invested a further £150,000 in South West Brands Limited (SWB), a multi-brand …
News

Bayer Phase III trial results prove positive for diabetes patients

October 4, 2021 Sales and Marketing

Bayer has revealed positive results from their FIGARO-DKD Phase III trial of Kerendia (finerenone), which showcased the drug’s ability to …
News

Eli Lilly and India’s Cipla enter deal on diabetes treatments

October 4, 2021 Business Services, Sales and Marketing

Eli Lilly and Mumbai-based Cipla have announced a deal in which Cipla will sell and distribute two of Lilly’s best-selling …
News
az

FDA grants BTD for Daiichi Sankyo and AstraZeneca’s Enhertu

October 4, 2021 Research and Development, Sales and Marketing

AstraZeneca and Daiichi Sankyo have today announced that the FDA has granted Enhertu (fam-trastuzumab deruxtecan-nxki) breakthrough therapy designation (BTD) for …
News

US injectables supplier Hikma acquires Custopharm

September 27, 2021 Sales and Marketing

Multinational pharmaceutical company, Hikma Pharmaceuticals PLC, has announced that it has agreed to acquire Custopharm Inc from Water Street Healthcare …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025